懒惰人民
发表于 2025-3-28 18:19:25
https://doi.org/10.1007/978-3-662-33071-5 was probably more efficient (in terms of ypCR) than short course (25/5), and (4) capecitabine was as efficient as 5 FU but oxaliplatin was not adding benefit. Overall, the gains of nCRT remain modest and it is mainly a reduction in local relapse not exceeding 5 %, but no benefit in survival and nei
工作
发表于 2025-3-28 20:55:52
https://doi.org/10.1007/978-3-662-32623-7e response (pCR) rate was about 10 % higher in the delayed-surgery group. There were no differences in sphincter preservation and R0 resection rate between the two groups. Small studies suggest no differences in the oncological outcomes. Regarding elderly patients who were unfit for chemotherapy, sh
anticipate
发表于 2025-3-29 00:23:26
https://doi.org/10.1007/978-3-662-33291-7h treatment regimens. While there is hardly an increase in early toxicity after preoperative SCRT with immediate surgery, late toxicity is substantial compared to surgery alone. Early toxicity is more frequent when a longer interval between SCRT and surgery is used and is comparable to the toxicity
重画只能放弃
发表于 2025-3-29 06:30:01
http://reply.papertrans.cn/31/3008/300729/300729_44.png
敲竹杠
发表于 2025-3-29 07:58:37
Total Mesorectal Excision: Open, Laparoscopic or Roboticerative outcomes and similar oncologic results. However, the conversion rate of LTME is around 17 %. The literature supporting RTME is more limited. Robotic rectal resection appears to have similar postoperative and oncologic outcomes compared to LTME. RTME results in higher costs and possibly lower
易碎
发表于 2025-3-29 12:29:47
http://reply.papertrans.cn/31/3008/300729/300729_46.png
magnate
发表于 2025-3-29 17:22:09
Quality of Life After Surgery for Rectal Canceroadjuvant therapy (50 %). The most frequently used instruments were the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (QLQ-C30), its colorectal cancer specific module QLQ-CR38, and the Medical Outcomes Study Short-Form 36 items questionnaire. Findin
Fibroid
发表于 2025-3-29 21:08:27
http://reply.papertrans.cn/31/3008/300729/300729_48.png
uveitis
发表于 2025-3-30 03:26:34
http://reply.papertrans.cn/31/3008/300729/300729_49.png
bromide
发表于 2025-3-30 05:36:56
http://reply.papertrans.cn/31/3008/300729/300729_50.png